Cardiovascular involvement in multisystem inflammatory syndrome in children and midterm follow-up from a pediatric tertiary center in India.

Poovazhagi Varadarajan, Ritchie Sharon Solomon, Seenivasan Subramani, Ramesh Subramanian, Gomathy Srividya, Elilarasi Raghunathan
Author Information
  1. Poovazhagi Varadarajan: Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India.
  2. Ritchie Sharon Solomon: Department of Pediatric Cardiology, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India. ritchie_sharon@yahoo.com.
  3. Seenivasan Subramani: Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India.
  4. Ramesh Subramanian: Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India.
  5. Gomathy Srividya: Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India.
  6. Elilarasi Raghunathan: Department of Pediatrics, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil N��du, India.

Abstract

BACKGROUND: In multisystem inflammatory syndrome in children (MIS-C) with coronavirus disease 2019, there was paucity of data from low-income and middle-income countries on cardiovascular involvement and its longitudinal outcomes. We planned to estimate the pattern of cardiovascular involvement among children with MIS-C and its mid-term outcomes.
AIM: To determine association between cardiovascular abnormalities and clinical and laboratory parameters. To study the time-line for resolution of various abnormalities.
METHODS: In this prospective study done in a tertiary care hospital, 270 were recruited from June 2020 to January 2022. Baseline demographic data and clinical presentation were recorded. Laboratory parameters and echocardiography were done at admission. Follow-up was done at 2 weeks, 3 months, 6 months and 1 year after diagnosis. Descriptive statistics were used for parametric and non-parametric data. Risk factors were identified by multivariate regression analysis.
RESULTS: The 211 (78.2%) had cardiac involvement and 102 needed intensive care unit (ICU) admission. Cardiovascular abnormalities observed were shock 123 (45.6%), coronary dilatation 28 (10.4%), coronary aneurysm 77 (28.5%), left ventricular (LV) dysfunction 78 (29.3%), mitral regurgitation (MR) 77 (28.5%) and pericardial effusion 98 (36.3%). Coronary artery aneurysm/dilatation during follow-up at 2 weeks and 1 year were 25.7% and 0.9% respectively. Multivariate regression analysis revealed breathlessness [odds ratio (OR) = 3.91, 95%CI: 1.25-12.21, = 0.019] and hi-flow nasal cannula (HFNC) support (OR = 8.5, 95%CI: 1.06-68.38, = 0.044) as predictors of cardiovascular involvement. Higher mean age (OR = 1.16, 95%CI: 1.02-1.32, = 0.026), breathlessness (OR = 4.99, 95%CI: 2.05-12.20, < 0.001), gallop (OR = 4.45, 95%CI: 0.41-2.52, = 0.016), MR (OR = 3.61, 95%CI: 1.53-8.53, = 0.004) and invasive ventilation (OR = 4.01, 95%CI: 1.28-12.58, = 0.017) were predictive of LV dysfunction. Altered sensorium (OR = 4.96, 95%CI: 2.23-11.02, < 0.001), headache (OR = 6.61, 95%CI: 1.46-29.92, = 0.014), HFNC (OR = 7.03, 95%CI: 2.04-24.29, = 0.002), non-rebreathing mask usage (OR = 21.13, 95%CI: 9.00-49.61, < 0.001) and invasive ventilation (OR = 5.64, 95%CI: 1.42-22.45, = 0.014) were risk factors for shock. Anemia was a risk factor for coronary involvement (OR = 3.09, 95%CI: 1.79- 5.34, < 0.001).
CONCLUSION: Significant number of children with MIS-C had cardiovascular involvement contributing to higher ICU management. Although shock resolved quickly, resolution of ventricular function and coronary abnormalities were slower, and hence warrants a structured long-term follow-up protocol.

Keywords

References

  1. Nat Rev Rheumatol. 2015 Aug;11(8):475-82 [PMID: 25907703]
  2. Indian Pediatr. 2022 Apr 15;59(4):339-340 [PMID: 35410972]
  3. BMJ. 2020 Jun 3;369:m2094 [PMID: 32493739]
  4. Indian Pediatr. 2020 Nov 15;57(11):1015-1019 [PMID: 32788432]
  5. Eur J Pediatr. 2024 Jun;183(6):2683-2692 [PMID: 38517518]
  6. Circulation. 2017 Apr 25;135(17):e927-e999 [PMID: 28356445]
  7. Crit Care. 2020 Nov 26;24(1):666 [PMID: 33243303]
  8. Front Pediatr. 2022 Mar 02;10:829420 [PMID: 35311051]
  9. Eur J Pediatr. 2021 Feb;180(2):307-322 [PMID: 32803422]
  10. EClinicalMedicine. 2020 Sep;26:100527 [PMID: 32923992]
  11. N Engl J Med. 2021 Jul 1;385(1):23-34 [PMID: 34133855]
  12. JAMA. 2020 Jul 21;324(3):259-269 [PMID: 32511692]
  13. N Engl J Med. 2020 Jul 23;383(4):334-346 [PMID: 32598831]
  14. J Paediatr Child Health. 2022 Jan;58(1):136-140 [PMID: 34339544]
  15. Pediatr Res. 2022 Jul;92(1):275-283 [PMID: 34584222]
  16. Pediatrics. 2003 May;111(5 Pt 1):1124-5 [PMID: 12728105]
  17. J Trop Pediatr. 2021 Jan 29;67(1): [PMID: 33513240]
  18. Korean J Pediatr. 2019 Aug;62(8):301-306 [PMID: 30744317]
  19. Circulation. 2021 Jan 5;143(1):21-32 [PMID: 33166189]
  20. J Nat Sci Biol Med. 2014 Jan;5(1):158-63 [PMID: 24678217]
  21. Indian Pediatr. 2023 May 15;60(5):389-390 [PMID: 36896751]
  22. Pediatr Pulmonol. 2021 May;56(5):837-848 [PMID: 33428826]
  23. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):239-44 [PMID: 23357243]
  24. Pediatr Cardiol. 2023 Feb;44(2):367-380 [PMID: 36214896]
  25. Lancet. 2020 Jun 6;395(10239):1771-1778 [PMID: 32410760]
  26. Indian Pediatr. 2020 Nov 15;57(11):1010-1014 [PMID: 32769230]
  27. J Clin Med. 2020 Oct 14;9(10): [PMID: 33066459]
  28. Lancet Infect Dis. 2020 Nov;20(11):e276-e288 [PMID: 32818434]
  29. Front Pediatr. 2022 Mar 11;10:834039 [PMID: 35377583]
  30. Indian Pediatr. 2022 Jul 15;59(7):563-569 [PMID: 35869878]
  31. JAMA. 2021 Mar 16;325(11):1074-1087 [PMID: 33625505]
  32. Circulation. 2021 Jan 5;143(1):78-88 [PMID: 33166178]
  33. Lancet Child Adolesc Health. 2021 Jul;5(7):473-482 [PMID: 34043958]
  34. Biology (Basel). 2022 Oct 08;11(10): [PMID: 36290378]
  35. Curr Cardiol Rep. 2021 Oct 1;23(11):168 [PMID: 34599465]
  36. Circulation. 2020 Aug 4;142(5):429-436 [PMID: 32418446]
  37. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-1080 [PMID: 32790663]
  38. Front Pediatr. 2018 Apr 04;6:79 [PMID: 29670871]

Word Cloud

Created with Highcharts 10.0.0=0OR95%CI:1involvementchildrencardiovascular2abnormalities3coronaryfollow-up4<001inflammatorysyndromeMIS-CdatadoneCardiovascularshock4528ventriculardysfunction561multisystemoutcomesclinicalparametersstudyresolutiontertiarycareadmissionweeksmonths6yearfactorsregressionanalysis78ICUaneurysm775%LV293%MRCoronaryarterybreathlessness21HFNCinvasiveventilation014riskBACKGROUND:coronavirusdisease2019paucitylow-incomemiddle-incomecountrieslongitudinalplannedestimatepatternamongmid-termAIM:determineassociationlaboratorytime-linevariousMETHODS:prospectivehospital270recruitedJune2020January2022BaselinedemographicpresentationrecordedLaboratoryechocardiographyFollow-updiagnosisDescriptivestatisticsusedparametricnon-parametricRiskidentifiedmultivariateRESULTS:2112%cardiac102neededintensiveunitobserved1236%dilatation104%leftmitralregurgitationpericardialeffusion9836aneurysm/dilatation257%9%respectivelyMultivariaterevealed[oddsratio9125-12019]hi-flownasalcannulasupport806-6838044predictorsHighermeanage1602-1320269905-1220gallop41-25201653-8530040128-1258017predictiveAlteredsensorium9623-1102headache46-299270304-24002non-rebreathingmaskusage13900-496442-22Anemiafactor0979-34CONCLUSION:SignificantnumbercontributinghighermanagementAlthoughresolvedquicklyfunctionslowerhencewarrantsstructuredlong-termprotocolmidtermpediatriccenterIndiaLeftMidtermMultisystemShock

Similar Articles

Cited By